ARKK vs XBI
ARK Innovation ETF vs SPDR S&P Biotech ETF
ARKK—
ARK Innovation ETF
Active disruptive-innovation strategy.
Expense: —Yield: —
XBI—
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKK | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | State Street |
ARKK top holdings
Holdings data unavailable for ARKK.
XBI top holdings
Holdings data unavailable for XBI.
About ARKK
ARKK (ARK Innovation ETF) is Active disruptive-innovation strategy.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index.